J Drugs Dermatol. 2021 Jan 1;20(1):84-87. doi: 10.36849/JDD.5080.
Atopic dermatitis (AD) has been shown to have an increasing incidence in Asia, congruous with the trends observed worldwide. The severity of the condition has been associated with challenges in disease control. Moreover, a significant number of patients do not adhere to their physicians’ recommendations correctly and prefer alternative treatments. Better education regarding the nature of the disease and its appropriate management may improve patient compliance and lead to better control. An ABC scheme of AD management entails anti-inflammatory, barrier repair and basic skin care strategies to adequately manage AD. It is an easy-to-follow model which helps lessen distress and improve the quality of life amongst patients. An expert panel composed of specialists in the field of dermatology and pediatric dermatology in the Philippines convened to review current data and management practices in order to provide key treatment recommendations and identify current gaps in the treatment of mild to moderate atopic dermatitis. This scientific expert panel, likewise, seeks to provide guidance for all healthcare professionals involved in the care and management of AD patients.J Drugs Dermatol. 2021;20(1):84-87. doi:10.36849/JDD.5080.
特应性皮炎(AD)在亚洲的发病率呈上升趋势,与全球观察到的趋势一致。该疾病的严重程度与疾病控制方面的挑战有关。此外,相当数量的患者不能正确遵循医生的建议,而是选择替代疗法。更好地了解疾病的性质及其适当的管理方法,可以提高患者的依从性,从而更好地控制疾病。AD 管理的 ABC 方案涉及抗炎、修复屏障和基本皮肤护理策略,以充分管理 AD。这是一个易于遵循的模型,有助于减轻患者的痛苦并提高生活质量。一个由菲律宾皮肤科和儿童皮肤科专家组成的专家小组召开会议,审查当前的数据和管理实践,以提供关键的治疗建议,并确定轻度至中度特应性皮炎治疗中的当前差距。这个科学专家小组同样旨在为所有参与 AD 患者护理和管理的医疗保健专业人员提供指导。J 皮肤病药物杂志。2021;20(1):84-87. doi:10.36849/JDD.5080.